Susan

Detailed equity research and balanced portfolio insights for serious investors who want analysis over hype. Invest with good reason here.

[Susan @StockSusan1]

I don't recommend inferior stocks.

This stock will change your current financial situation and improve your life.

🎯It's enough to buy 100 shares.

💰Current price: 69.35 USD

💰Total investment: $7,000

💰Price target range: $75-$78

💸Potential profit: $60,000 - $70,000

The stock has now adjusted back to $70, which is the most suitable price before a sharp rise.

This company has an upward potential of 750%-870%.

#Stocks #Stock Market #Investment #Trading #Swing Trading #American Stocks #Wall Street #Wealth #Financial Freedom

[Susan @StockSusan1]

@vnkumarvnk Have a nice weekend!🌹🫰🏻

[Susan @StockSusan1]

@LazaroInvestor If the design is forced to be changed in the end, the impact on advertising efficiency may be more worthy of attention than the compensation. What do you think about the risk of product functions being changed?

[Susan @StockSusan1]

@unusual_whales $MRNA is indeed exaggerated this week. The increase of 150%+ is mainly due to the success of the personalized mRNA melanoma vaccine phase III in cooperation with Merck.

[Susan @StockSusan1]

@kisar_ 🙏🏻

[Susan @StockSusan1]

@Brownmoose yes

[Susan @StockSusan1]

@NoLimitGains 😂 😂🤣lol

[Susan @StockSusan1]

San Diego and Los Angeles have risen so much, mainly because of the limited supply + the concentration of high-income industries. Many cities in the central and western regions have lost both population and industry, and house prices naturally cannot rise. In the long run, regional differentiation will only be more obvious.

[Susan @StockSusan1]

@HyperTechInvest Thank you for sharing. $65–80B is equivalent to 5–7% of the market value. Q3 will first distribute about $22B in dividends, and the remaining repurchase + additional dividend combination will be the key.

Which side do you think the final buyback ratio will be more inclined to?

[Susan @StockSusan1]

@FromValue @fiscal_ai If the company's debt is higher than cash + investment + FCF, which deeper indicators will you prioritize? Interest coverage rate or debt maturity structure?

[Susan @StockSusan1]

@Han_Akamatsu @eWhispers NVDA guidelines, data center needs, and the growth quality of CRWD will be the key.

[Susan @StockSusan1]

@seth_fin Agree on the short squeeze.
You think they go for the longs from here, or still some more downside first?🤔

[Susan @StockSusan1]

@travladd Agree. Passion gets labeled as paid way too easily in this space. Respect for actually disclosing.”

[Susan @StockSusan1]

I totally agree with your analysis. Short-term emotions and dilution worries will indeed suppress prices, but ATMs are essentially flexible tools, not immediately diluted in full. The company has enough cash and strong demand, and the expansion of production capacity is the core. If it is implemented well, it will be a long-term opportunity. What do you think of the follow-up CapEx rhythm?

[Susan @StockSusan1]

@Mariusz_Invest SPCX fell a lot from the high point after the IPO in June, and now it is back to near the IPO price. The story of overvaluation sounds beautiful, but there are often fluctuations after landing.

[Susan @StockSusan1]

@TradexWhisperer Samsung can raise the price of 4nm by 10-15%, indicating that alternative production capacity other than TSM has also begun to have the right to price.

[Susan @StockSusan1]

@HunterAllen4 AXTI is indeed underestimated as an upstream InP bottleneck. Compared with AAOI, LITE and COHR, will it be more elastic?

[Susan @StockSusan1]

@WheelieInvestor Yeah the dump was needed after that run. Where do you see the short-term support for HYPE? 75 or lower?

[Susan @StockSusan1]

After the breakdown of the Canada-U.S. trade negotiations, 50% tariffs will be implemented, and the supply chain and related sectors (steel and aluminum, automobiles, dairy products) will fluctuate in the short term. Will the US dollar's revenge against the US dollar further push up inflation in North America?